English
Segment disclosures
Company overviewCVS HEALTH CORP
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Corporate And Reconciling Items · Corporate And Other Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=cvs:CorporateAndReconcilingItemsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:CorporateAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 147000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 273000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 126000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 484000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 133000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 362000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 96000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 229000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 133000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 451000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 142000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 368000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 111000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 226000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 115000000 | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 451000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 105000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 376000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 83000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 271000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 188000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 530000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 142000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 378000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 721000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Corporate And Reconciling Items · Corporate And Other Segment · Restatement Adjustment
Consolidation Items · Statement Business Segments · Restatement
Source dimensions
srt:ConsolidationItemsAxis=cvs:CorporateAndReconcilingItemsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:CorporateAndOtherSegmentMember;srt:RestatementAxis=srt:RestatementAdjustmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 0 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Corporate And Reconciling Items · Corporate And Other Segment · Scenario Previously Reported
Consolidation Items · Statement Business Segments · Restatement
Source dimensions
srt:ConsolidationItemsAxis=cvs:CorporateAndReconcilingItemsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:CorporateAndOtherSegmentMember;srt:RestatementAxis=srt:ScenarioPreviouslyReportedMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 142000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 378000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
Intersegment Elimination · Health Care Benefits Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | -31000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | -63000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-03-31 | -32000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | -118000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | -49000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | -87000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | -20000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | -38000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | -18000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | -72000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | -18000000 Restated | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | -54000000 Restated | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | -18000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | -36000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | -18000000 Restated | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | -81000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 20000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 62000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 21000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | -76000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 20000000 Restated | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 60000000 Restated | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 23000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 46000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 23000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 85000000 | USD | 2022-02-09 · 11:37:35.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 21000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 62000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 21000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 41000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 20000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 58000000 | USD | 2022-02-09 · 11:37:35.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 20000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 51000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 23000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 31000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 8000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
Intersegment Elimination · Health Services Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | -6407000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | -12035000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-03-31 | -5628000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | -25802000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | -6913000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | -18603000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | -6338000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | -11690000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | -5352000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | -15304000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | -3336000000 Restated | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | -10634000000 Restated | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | -3479000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | -7298000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | -3819000000 Restated | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | -12826000000 Restated | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2827000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 9790000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 3780000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | -11608000000 Restated | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 2710000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 9006000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 9980000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Intersegment Elimination · Pharmacy And Consumer Health Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyAndConsumerHealthSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | -10762000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | -20999000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-03-31 | -10237000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | -45643000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | -11773000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | -33247000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | -11115000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | -21474000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | -10359000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | -41036000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | -10908000000 Restated | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | -29859000000 Restated | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | -9864000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | -18951000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | -9087000000 | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | -39020000000 Restated | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 9553000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 28756000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | -35901000000 Restated | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 9240000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 26710000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 36185000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Intersegment Elimination · Pharmacy Services Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 11449000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 2671000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 8889000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 2953000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 6218000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 3265000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 9828000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 2195000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 7772000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 2569000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 5577000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 3008000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 9275000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 2266000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 5131000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2865000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
Intersegment Elimination · Retail Long Term Care Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 33764000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 8722000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 25074000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 8352000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 16352000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 8000000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 34010000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 8678000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 25309000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 8543000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 16631000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 8088000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 30990000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 7475000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 14867000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 7392000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
Intersegment Elimination · Corporate And Other
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Front Store Revenue · Health Care Benefits Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:FrontStoreRevenueMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Front Store Revenue · Pharmacy Services Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:FrontStoreRevenueMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Front Store Revenue · Retail Long Term Care Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:FrontStoreRevenueMember;us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 4653000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 9861000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 5208000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Pharmacy Revenue · Health Care Benefits Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:PharmacyRevenueMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Pharmacy Revenue · Pharmacy Services Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:PharmacyRevenueMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 34645000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 69419000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 34774000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Pharmacy Revenue · Retail Long Term Care Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:PharmacyRevenueMember;us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 16870000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 34225000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 17355000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Premiums · Health Care Benefits Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:PremiumsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 16913000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 34534000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 17621000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Premiums · Pharmacy Services Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:PremiumsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Premiums · Retail Long Term Care Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:PremiumsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Product And Service Other · Health Care Benefits Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 1428000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 2912000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1484000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Product And Service Other · Pharmacy Services Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 244000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 453000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 209000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Product And Service Other · Retail Long Term Care Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 139000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 325000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 186000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Sales Channel Other · Health Services Segment
Consolidation Items · Contract With Customer Sales Channel · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ContractWithCustomerSalesChannelAxis=cvs:SalesChannelOtherMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 2582000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 9296000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 2467000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 6913000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2180000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 4446000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2266000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 10793000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2780000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 8013000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2674000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 5233000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6134000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
Operating Segments · Sales Channel Other · Pharmacy Services Segment
Consolidation Items · Contract With Customer Sales Channel · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ContractWithCustomerSalesChannelAxis=cvs:SalesChannelOtherMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 1102000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 269000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 777000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 760000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 179000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 520000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 822000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 244000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 453000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 209000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Sales Channel Directly To Consumer · Health Services Segment
Consolidation Items · Contract With Customer Sales Channel · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelDirectlyToConsumerMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 20506000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 79334000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 20392000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 58071000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 19611000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 37679000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 18068000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 70877000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 17214000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 52127000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 17651000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 34913000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 67992000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
Operating Segments · Sales Channel Directly To Consumer · Pharmacy Services Segment
Consolidation Items · Contract With Customer Sales Channel · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelDirectlyToConsumerMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 18030000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 34404000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 60547000000 | USD | 2022-02-09 · 11:37:35.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 15235000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 29483000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 56071000000 | USD | 2022-02-09 · 11:37:35.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 14109000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 27783000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 13674000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Sales Channel Through Intermediary · Health Services Segment
Consolidation Items · Contract With Customer Sales Channel · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelThroughIntermediaryMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 25149000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 101775000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 26408000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 74187000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 24665000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 47779000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 23114000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 91650000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 24136000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 66448000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 21848000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 42312000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 112718000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
Operating Segments · Sales Channel Through Intermediary · Pharmacy Services Segment
Consolidation Items · Contract With Customer Sales Channel · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelThroughIntermediaryMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 97668000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 91715000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 85045000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 20536000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 41636000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 21100000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Health Care Benefits Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 37538000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 73509000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 35971000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 143354000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 35993000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 107061000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 36258000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 71068000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 34810000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 130665000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 32996000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 97707000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 32475000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 64711000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 32236000000 | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 105646000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 26296000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 78920000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 26747000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 52624000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 25877000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 91350000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 22496000000 Restated | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 68331000000 Restated | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 22756000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 45865000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 82186000000 | USD | 2022-02-09 · 11:37:35.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 20479000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 61487000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 20525000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 41008000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 75467000000 | USD | 2022-02-09 · 11:37:35.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 18698000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 56364000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 18468000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 37666000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 19198000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Health Services Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 51795000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 100032000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 48237000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 190425000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 49266000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 139181000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 46453000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 89915000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 43462000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 173605000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 44129000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 126585000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 42171000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 82456000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 40285000000 | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 186843000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 46891000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 137697000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 44591000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 169576000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
Operating Segments · Pharmacy And Consumer Health Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyAndConsumerHealthSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 33816000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 65805000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 31989000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 139367000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 36214000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 101707000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 33581000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 65493000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 31912000000 | USD | 2026-05-06 · 10:33:38.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 124500000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 32423000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 90986000000 | USD | 2025-10-29 · 10:34:58.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 29838000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 58563000000 | USD | 2025-07-31 · 10:34:19.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 28725000000 | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 116763000000 | USD | 2026-02-10 · 11:36:59.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 28872000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 85578000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 28784000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 56706000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 108596000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 101620000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Operating Segments · Pharmacy And Consumer Health Segment · Restatement Adjustment
Consolidation Items · Statement Business Segments · Restatement
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyAndConsumerHealthSegmentMember;srt:RestatementAxis=srt:RestatementAdjustmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 2002000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1515000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Operating Segments · Pharmacy Services Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 169236000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 43216000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 125489000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 42812000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 82273000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 39461000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 153022000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 39046000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 113681000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 38314000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 74635000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 36321000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 141938000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 35711000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 105583000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 34889000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 69872000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 34983000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Operating Segments · Pharmacy Services Segment · Sales Channel Other
Consolidation Items · Statement Business Segments · Contract With Customer Sales Channel
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;us-gaap:ContractWithCustomerSalesChannelAxis=cvs:SalesChannelOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 245000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 508000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 161000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 341000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
Operating Segments · Pharmacy Services Segment · Sales Channel Directly To Consumer
Consolidation Items · Statement Business Segments · Contract With Customer Sales Channel
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelDirectlyToConsumerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 70466000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 17935000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 52339000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 60547000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 15202000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 44685000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 56071000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
Operating Segments · Pharmacy Services Segment · Sales Channel Through Intermediary
Consolidation Items · Statement Business Segments · Contract With Customer Sales Channel
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelThroughIntermediaryMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 25012000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 72373000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 23665000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 68476000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
Operating Segments · Retail Long Term Care Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 106594000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 26706000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 78410000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 100105000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 24992000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 72994000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 91198000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 21662000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 44411000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 22749000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Front Store Revenue · Corporate And Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cvs:FrontStoreRevenueMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Pharmacy Revenue · Health Care Benefits Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=cvs:PharmacyRevenueMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Pharmacy Revenue · Pharmacy Services Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=cvs:PharmacyRevenueMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 35505000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 104924000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Pharmacy Revenue · Retail Long Term Care Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=cvs:PharmacyRevenueMember;us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 17608000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 51833000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Pharmacy Revenue · Corporate And Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cvs:PharmacyRevenueMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Premiums · Health Care Benefits Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=cvs:PremiumsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 17165000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 51699000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Premiums · Retail Long Term Care Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=cvs:PremiumsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Premiums · Corporate And Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cvs:PremiumsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 17000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 50000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 14000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 33000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 19000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Product And Service Other · Corporate And Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 16000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 33000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 15000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 17000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2000000 | USD | 2020-05-06 · 10:39:08.000Z | Open filing evidence |
Restatement Adjustment · Corporate And Reconciling Items · Corporate And Other Segment
Restatement · Consolidation Items · Statement Business Segments
Source dimensions
srt:RestatementAxis=srt:RestatementAdjustmentMember;srt:ConsolidationItemsAxis=cvs:CorporateAndReconcilingItemsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:CorporateAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 0 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
Restatement Adjustment · Operating Segments · Health Care Benefits Segment
Restatement · Consolidation Items · Statement Business Segments
Source dimensions
srt:RestatementAxis=srt:RestatementAdjustmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | -15000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | -45000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
Restatement Adjustment · Health Care Benefits Segment · Operating Segments
Restatement · Statement Business Segments · Consolidation Items
Source dimensions
srt:RestatementAxis=srt:RestatementAdjustmentMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | -15000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
Restatement Adjustment · Health Services Segment · Operating Segments
Restatement · Statement Business Segments · Consolidation Items
Source dimensions
srt:RestatementAxis=srt:RestatementAdjustmentMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 38000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 318000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 154000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
Restatement Adjustment · Pharmacy And Consumer Health Segment · Operating Segments
Restatement · Statement Business Segments · Consolidation Items
Source dimensions
srt:RestatementAxis=srt:RestatementAdjustmentMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyAndConsumerHealthSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 531000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1471000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
Scenario Previously Reported · Corporate And Reconciling Items · Corporate And Other Segment
Restatement · Consolidation Items · Statement Business Segments
Source dimensions
srt:RestatementAxis=srt:ScenarioPreviouslyReportedMember;srt:ConsolidationItemsAxis=cvs:CorporateAndReconcilingItemsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:CorporateAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 530000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 721000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Scenario Previously Reported · Operating Segments · Health Care Benefits Segment
Restatement · Consolidation Items · Statement Business Segments
Source dimensions
srt:RestatementAxis=srt:ScenarioPreviouslyReportedMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 22511000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 68376000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
Scenario Previously Reported · Operating Segments · Pharmacy And Consumer Health Segment
Restatement · Consolidation Items · Statement Business Segments
Source dimensions
srt:RestatementAxis=srt:ScenarioPreviouslyReportedMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyAndConsumerHealthSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 106594000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 100105000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Scenario Previously Reported · Health Services Segment · Operating Segments
Restatement · Statement Business Segments · Consolidation Items
Source dimensions
srt:RestatementAxis=srt:ScenarioPreviouslyReportedMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 43216000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 125489000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 42812000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 82273000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
Scenario Previously Reported · Pharmacy And Consumer Health Segment · Operating Segments
Restatement · Statement Business Segments · Consolidation Items
Source dimensions
srt:RestatementAxis=srt:ScenarioPreviouslyReportedMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyAndConsumerHealthSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 26706000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 78410000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
Sales Channel Other · Operating Segments · Health Services Segment
Contract With Customer Sales Channel · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=cvs:SalesChannelOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 2266000000 | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 10793000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2780000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 8013000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2559000000 | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6134000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1906000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4269000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 854000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2783000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
Sales Channel Other · Operating Segments · Pharmacy Services Segment
Contract With Customer Sales Channel · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=cvs:SalesChannelOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 263000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 760000000 | USD | 2022-02-09 · 11:37:35.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 179000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 520000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 180000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 822000000 | USD | 2022-02-09 · 11:37:35.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 206000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 659000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
Sales Channel Other · Health Services Segment · Operating Segments
Contract With Customer Sales Channel · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=cvs:SalesChannelOtherMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 2602000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 5184000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2180000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 4446000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6134000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 854000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2783000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 819000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3246000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Sales Channel Other · Pharmacy Services Segment · Operating Segments
Contract With Customer Sales Channel · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=cvs:SalesChannelOtherMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-04-01 – 2021-06-30 | 161000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 341000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 180000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 244000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 453000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 209000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
Sales Channel Directly To Consumer · Operating Segments · Health Services Segment
Contract With Customer Sales Channel · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelDirectlyToConsumerMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 18068000000 | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 70877000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 17214000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 52127000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 17262000000 | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 67992000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 17004000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 50378000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 16145000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 63825000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
Sales Channel Directly To Consumer · Operating Segments · Pharmacy Services Segment
Contract With Customer Sales Channel · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelDirectlyToConsumerMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 16374000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 15202000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 44685000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 14248000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 14032000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 41815000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
Sales Channel Directly To Consumer · Health Services Segment · Operating Segments
Contract With Customer Sales Channel · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelDirectlyToConsumerMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 22577000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 43083000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 19611000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 37679000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 16145000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 14668000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
Sales Channel Directly To Consumer · Pharmacy Services Segment · Operating Segments
Contract With Customer Sales Channel · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelDirectlyToConsumerMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-03-31 | 14248000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 13674000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
Sales Channel Through Intermediary · Operating Segments · Health Services Segment
Contract With Customer Sales Channel · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelThroughIntermediaryMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 23114000000 | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 91650000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 24136000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 66448000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 20464000000 | USD | 2025-05-01 · 10:35:46.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 112718000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 27981000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 83050000000 | USD | 2024-11-06 · 11:35:35.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 27592000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 102968000000 | USD | 2025-02-12 · 11:47:38.000Z | Open filing evidence |
Sales Channel Through Intermediary · Operating Segments · Pharmacy Services Segment
Contract With Customer Sales Channel · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelThroughIntermediaryMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 24537000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 47361000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 22824000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 23665000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 68476000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 22918000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 44811000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 21893000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 21473000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 63109000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
Sales Channel Through Intermediary · Health Services Segment · Operating Segments
Contract With Customer Sales Channel · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelThroughIntermediaryMember;us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 26617000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 51766000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 24665000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 47779000000 | USD | 2026-08-05 · 10:33:43.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 27981000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 83050000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 27592000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 26334000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 76358000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 24128000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
Sales Channel Through Intermediary · Pharmacy Services Segment · Operating Segments
Contract With Customer Sales Channel · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelThroughIntermediaryMember;us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-04-01 – 2021-06-30 | 22918000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 44811000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 20536000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 41636000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
Health Care Benefits Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 22511000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 68376000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 22756000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 45865000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 23109000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 20479000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 61487000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 20525000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 41008000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 20483000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 18698000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 56364000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 18468000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 37666000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 19198000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
Health Care Benefits Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 18000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 36000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 81000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 21000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 42000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 21000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 76000000 Restated | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 20000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 40000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 20000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 76000000 Restated | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 21000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 41000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 58000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 20000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 51000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 23000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 31000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
Health Care Benefits Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 105646000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 26747000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 52624000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 25877000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 91350000000 Restated | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 22741000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 45835000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 23094000000 Restated | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 82119000000 Restated | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 20525000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 41008000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 20483000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 75467000000 | USD | 2023-02-08 · 11:37:38.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 18698000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 56364000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 18468000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 37666000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 19198000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
Health Care Benefits Segment · Operating Segments · Front Store Revenue
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:FrontStoreRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Health Care Benefits Segment · Operating Segments · Restatement Adjustment
Statement Business Segments · Consolidation Items · Restatement
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:RestatementAxis=srt:RestatementAdjustmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | -59000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | -67000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Health Care Benefits Segment · Product And Service Other · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 1412000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 4324000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Health Care Benefits Segment · Restatement Adjustment · Operating Segments
Statement Business Segments · Restatement · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember;srt:RestatementAxis=srt:RestatementAdjustmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | -15000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | -30000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
Health Care Benefits Segment · Scenario Previously Reported · Operating Segments
Statement Business Segments · Restatement · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthCareBenefitsSegmentMember;srt:RestatementAxis=srt:ScenarioPreviouslyReportedMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 91409000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 22756000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 45865000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 23109000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 82186000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Health Services Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 3479000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 7298000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 3183000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 6963000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 3780000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 2992000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 6296000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 3304000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
Health Services Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 42171000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 82456000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 186843000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 46891000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 137697000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 46215000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 90806000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 44591000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 169576000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 43254000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 125807000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 42938000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 82553000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 39615000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 153892000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Health Services Segment · Operating Segments · Restatement Adjustment
Statement Business Segments · Consolidation Items · Restatement
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:RestatementAxis=srt:RestatementAdjustmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 340000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 870000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Health Services Segment · Operating Segments · Sales Channel Other
Statement Business Segments · Consolidation Items · Contract With Customer Sales Channel
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ContractWithCustomerSalesChannelAxis=cvs:SalesChannelOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 1906000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4269000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1509000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 2363000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 602000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2180000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 759000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1578000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
Health Services Segment · Operating Segments · Sales Channel Directly To Consumer
Statement Business Segments · Consolidation Items · Contract With Customer Sales Channel
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelDirectlyToConsumerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 67992000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 17004000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 50378000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 63825000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 16318000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 47269000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 53812000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Health Services Segment · Restatement Adjustment · Operating Segments
Statement Business Segments · Restatement · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:RestatementAxis=srt:RestatementAdjustmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 126000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 280000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
Health Services Segment · Scenario Previously Reported · Operating Segments
Statement Business Segments · Restatement · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;srt:RestatementAxis=srt:ScenarioPreviouslyReportedMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 169236000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 39461000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 153022000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Health Services Segment · Sales Channel Other · Operating Segments
Statement Business Segments · Contract With Customer Sales Channel · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;us-gaap:ContractWithCustomerSalesChannelAxis=cvs:SalesChannelOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 2674000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 5233000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1509000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 2363000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
Health Services Segment · Sales Channel Directly To Consumer · Operating Segments
Statement Business Segments · Contract With Customer Sales Channel · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelDirectlyToConsumerMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 17651000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 34913000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 17229000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 33374000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 16283000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 30951000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
Health Services Segment · Sales Channel Through Intermediary · Operating Segments
Statement Business Segments · Contract With Customer Sales Channel · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:HealthServicesSegmentMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelThroughIntermediaryMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 21848000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 42312000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 112718000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 27477000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 55069000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 102968000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 25896000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 50024000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 96834000000 | USD | 2024-02-07 · 11:52:35.000Z | Open filing evidence |
Pharmacy And Consumer Health Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyAndConsumerHealthSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 9864000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 18951000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 9087000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 9704000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 19203000000 | USD | 2024-08-07 · 10:35:29.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 9499000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 8887000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 17470000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 8583000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
Pharmacy And Consumer Health Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyAndConsumerHealthSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 28725000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 28872000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 85578000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 28784000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 56706000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 27922000000 | USD | 2024-05-01 · 10:40:00.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 27237000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 79881000000 | USD | 2023-11-01 · 10:38:24.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 26746000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 52644000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 25898000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
Pharmacy And Consumer Health Segment · Restatement Adjustment · Operating Segments
Statement Business Segments · Restatement · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyAndConsumerHealthSegmentMember;srt:RestatementAxis=srt:RestatementAdjustmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 460000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 940000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 480000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
Pharmacy And Consumer Health Segment · Scenario Previously Reported · Operating Segments
Statement Business Segments · Restatement · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyAndConsumerHealthSegmentMember;srt:RestatementAxis=srt:ScenarioPreviouslyReportedMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 26286000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 51704000000 | USD | 2023-08-02 · 10:36:58.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 25418000000 | USD | 2023-05-03 · 10:38:46.000Z | Open filing evidence |
Pharmacy Services Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 43216000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 125489000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 42812000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 82273000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 39461000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 39046000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 113681000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 38314000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 74635000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 36321000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 35711000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 105583000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 34889000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 69872000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 34983000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
Pharmacy Services Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 2195000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 7772000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 9275000000 | USD | 2021-02-16 · 11:47:54.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 2219000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 7350000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
Pharmacy Services Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-04-01 – 2021-06-30 | 38314000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 74635000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 36321000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 141938000000 | USD | 2021-02-16 · 11:47:54.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 35711000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 105583000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 34889000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 69872000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 34983000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
Pharmacy Services Segment · Operating Segments · Front Store Revenue
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:FrontStoreRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Pharmacy Services Segment · Operating Segments · Sales Channel Other
Statement Business Segments · Consolidation Items · Contract With Customer Sales Channel
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ContractWithCustomerSalesChannelAxis=cvs:SalesChannelOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 822000000 | USD | 2021-02-16 · 11:47:54.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 206000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 659000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Pharmacy Services Segment · Operating Segments · Sales Channel Directly To Consumer
Statement Business Segments · Consolidation Items · Contract With Customer Sales Channel
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelDirectlyToConsumerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 56071000000 | USD | 2021-02-16 · 11:47:54.000Z | Open filing evidence |
Pharmacy Services Segment · Operating Segments · Sales Channel Through Intermediary
Statement Business Segments · Consolidation Items · Contract With Customer Sales Channel
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelThroughIntermediaryMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 85045000000 | USD | 2021-02-16 · 11:47:54.000Z | Open filing evidence |
Pharmacy Services Segment · Premiums · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ProductOrServiceAxis=cvs:PremiumsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Pharmacy Services Segment · Product And Service Other · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 206000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 659000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Pharmacy Services Segment · Sales Channel Directly To Consumer · Operating Segments
Statement Business Segments · Contract With Customer Sales Channel · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelDirectlyToConsumerMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-04-01 – 2021-06-30 | 15235000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 29483000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 14032000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 41815000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 14109000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 27783000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
Pharmacy Services Segment · Sales Channel Through Intermediary · Operating Segments
Statement Business Segments · Contract With Customer Sales Channel · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:PharmacyServicesSegmentMember;us-gaap:ContractWithCustomerSalesChannelAxis=us-gaap:SalesChannelThroughIntermediaryMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-03-31 | 21893000000 | USD | 2021-05-04 · 10:37:00.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 21473000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 63109000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Retail Long Term Care Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 26706000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 78410000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 26286000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 51704000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 25418000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 24992000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 72994000000 | USD | 2022-11-02 · 10:36:26.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 24728000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 48002000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 23274000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 22725000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 67136000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 21662000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 44411000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
Retail Long Term Care Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 8678000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 25309000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 8543000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 16631000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 30990000000 | USD | 2021-02-16 · 11:47:54.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 7955000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 22822000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 7475000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 14867000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
Retail Long Term Care Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 26286000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 51704000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 25418000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 24992000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 72994000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 24728000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 48002000000 | USD | 2022-08-03 · 10:35:56.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 23274000000 | USD | 2022-05-04 · 10:35:04.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 22725000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 67136000000 | USD | 2021-11-03 · 10:46:46.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 21662000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 44411000000 | USD | 2021-08-04 · 10:36:56.000Z | Open filing evidence |
Retail Long Term Care Segment · Operating Segments · Front Store Revenue
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cvs:FrontStoreRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 4740000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 14601000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Retail Long Term Care Segment · Product And Service Other · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cvs:RetailLongTermCareSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 377000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 702000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Corporate And Other
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 116000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 292000000 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 86000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 176000000 | USD | 2020-08-05 · 10:37:51.000Z | Open filing evidence |
Corporate And Other · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
Corporate And Other · Front Store Revenue
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ProductOrServiceAxis=cvs:FrontStoreRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 2020-11-06 · 11:41:29.000Z | Open filing evidence |